Bourasset, Fanchon <br/><br/>
Reduction of the cerebrovascular volume in a transgenic mouse model of Alzheimer's disease.  [electronic resource] 

 -  Neuropharmacology  Mar 2009 
 - 808-13 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1873-7064 
<br/><br/><label>Standard No.: </label>10.1016/j.neuropharm.2009.01.006  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Alzheimer Disease--metabolism<br/>Amyloid beta-Peptides--metabolism<br/>Animals<br/>Basement Membrane--metabolism<br/>Blood Vessels--metabolism<br/>Brain--pathology<br/>Brain Chemistry--drug effects<br/>Cerebrovascular Circulation--physiology<br/>Collagen Type I--metabolism<br/>Collagen Type IV--metabolism<br/>Diazepam--metabolism<br/>GABA Modulators--metabolism<br/>Glucose--metabolism<br/>Humans<br/>Immunohistochemistry<br/>Mice<br/>Mice, Transgenic<br/>tau Proteins--metabolism